CGEM logo

Cullinan Oncology (CGEM) Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$83.00 M
-$15.43 M-15.67%

December 1, 2024


Summary


Performance

CGEM Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCGEMbalance sheetmetrics:

Quarterly Cash And Cash Equivalents

$83.00 M
-$19.08 M-18.69%

December 1, 2024


Summary


Performance

CGEM Quarterly Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCGEMbalance sheetmetrics:

Cash And Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

CGEM Cash And Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-15.7%0.0%
3 y3 years+38.9%0.0%
5 y5 years+31.2%0.0%

CGEM Cash And Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-46.8%+38.9%-76.5%+38.9%
5 y5-year-50.6%+38.9%-76.5%+38.9%
alltimeall time-50.6%-100.0%-76.5%+38.9%

Cullinan Oncology Cash And Cash Equivalents History

DateAnnualQuarterly
Dec 2024
$83.00 M(-15.7%)
$83.00 M(-18.7%)
Sep 2024
-
$102.08 M(-11.2%)
Jun 2024
-
$115.02 M(+55.0%)
Mar 2024
-
$74.23 M(-24.6%)
Dec 2023
$98.43 M(-37.0%)
$98.43 M(+51.8%)
Sep 2023
-
$64.85 M(-54.3%)
Jun 2023
-
$141.83 M(+16.1%)
Mar 2023
-
$122.13 M(-21.8%)
Dec 2022
$156.15 M(+161.2%)
$156.15 M(-35.6%)
Sep 2022
-
$242.66 M(-31.4%)
Jun 2022
-
$353.56 M(+364.5%)
Mar 2022
-
$76.12 M(+27.3%)
Dec 2021
$59.77 M
$59.77 M(-32.2%)
Sep 2021
-
$88.11 M(-28.8%)
Jun 2021
-
$123.67 M(-57.9%)
DateAnnualQuarterly
Mar 2021
-
$293.54 M(+74.5%)
Dec 2020
$168.20 M(+165.9%)
$168.20 M(+1.3%)
Sep 2020
-
$166.00 M(+162.4%)
Dec 2019
$63.25 M(+87.0%)
$63.25 M
Dec 2018
$33.83 M(>+9900.0%)
-
Dec 2016
$100.00(0.0%)
-
Dec 2015
$100.00(-94.4%)
-
Dec 2014
$1800.00(-10.0%)
-
Dec 2013
$2000.00(+566.7%)
-
Dec 2012
$300.00(-66.7%)
-
Dec 2011
$900.00(-35.7%)
-
Dec 2010
$1400.00(+250.0%)
-
Dec 2009
$400.00(>+9900.0%)
-
Dec 2008
$0.00(-100.0%)
-
Dec 2007
$6000.00
-

FAQ

  • What is Cullinan Oncology annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Cullinan Oncology?
  • What is Cullinan Oncology annual cash & cash equivalents year-on-year change?
  • What is Cullinan Oncology quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for Cullinan Oncology?
  • What is Cullinan Oncology quarterly cash and cash equivalents year-on-year change?

What is Cullinan Oncology annual cash & cash equivalents?

The current annual cash & cash equivalents of CGEM is $83.00 M

What is the all time high annual cash & cash equivalents for Cullinan Oncology?

Cullinan Oncology all-time high annual cash & cash equivalents is $168.20 M

What is Cullinan Oncology annual cash & cash equivalents year-on-year change?

Over the past year, CGEM annual cash & cash equivalents has changed by -$15.43 M (-15.67%)

What is Cullinan Oncology quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of CGEM is $83.00 M

What is the all time high quarterly cash and cash equivalents for Cullinan Oncology?

Cullinan Oncology all-time high quarterly cash and cash equivalents is $353.56 M

What is Cullinan Oncology quarterly cash and cash equivalents year-on-year change?

Over the past year, CGEM quarterly cash and cash equivalents has changed by $0.00 (0.00%)